Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Serologic testing for sexually transmitted diseases

D L Thomas1, T C Quinn

  • 1Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, Maryland.

Infectious Disease Clinics of North America
|December 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Not all voxels are created equal: Reducing estimation bias in regional NODDI metrics using tissue-weighted means.

NeuroImage·2021
Same author

Genome-wide association study of milk production traits in a crossbred dairy sheep population using three statistical models.

Animal genetics·2020
Same author

Non-Invasive MRI of Blood-Cerebrospinal Fluid Barrier Function.

Nature communications·2020
Same author

Emergency departments at the crossroads of intersecting epidemics (HIV, HCV, injection drug use and opioid overdose)-Estimating HCV incidence in an urban emergency department population.

Journal of viral hepatitis·2018
Same author

Invited review: Current production trends, farm structures, and economics of the dairy sheep and goat sectors.

Journal of dairy science·2018
Same author

Quantifying multiple sclerosis pathology in post mortem spinal cord using MRI.

NeuroImage·2018
Same journal

Prevention and Control of Clostridioides difficile Infection for the Infectious Diseases Clinician.

Infectious disease clinics of North America·2026
Same journal

Infection Control Strategies to Prevent Emergence and Transmission of Resistant Gram-Negative Bacteria.

Infectious disease clinics of North America·2026
Same journal

Preventing the Spread of Tuberculosis in Health Care Settings.

Infectious disease clinics of North America·2026
Same journal

Threats to Success: Principles of Infection Prevention and Control in Health Care Settings, Part 2: Device and Pathogen Management.

Infectious disease clinics of North America·2026
Same journal

Ventilator-Associated Events: Surveillance and Prevention.

Infectious disease clinics of North America·2026
Same journal

Nosocomial Fungal Infections: Epidemiology, Control Strategies, and Prevention of Candida and Other Yeasts.

Infectious disease clinics of North America·2026
See all related articles

This review examines serologic testing for sexually transmitted diseases (STDs), highlighting its use in diagnosis, therapy monitoring, and understanding disease spread. It evaluates the strengths and weaknesses of these tests for various pathogens.

Area of Science:

  • Clinical Microbiology
  • Infectious Diseases
  • Public Health

Background:

  • Serologic testing plays a crucial role in managing sexually transmitted diseases (STDs).
  • Current challenges and advancements in serologic assays for STDs require critical evaluation.

Purpose of the Study:

  • To review the current issues and utility of serologic testing for selected STDs.
  • To assess the strengths and weaknesses of serologic tests in diagnosis, therapy monitoring, and seroepidemiology.

Main Methods:

  • Literature review and critical analysis of existing serologic testing methodologies for specific STDs.
  • Evaluation of diagnostic accuracy, utility in monitoring treatment efficacy, and epidemiological relevance.

Main Results:

Related Experiment Videos

  • Serologic tests offer valuable insights for diagnosing STDs, monitoring treatment success, and understanding disease prevalence.
  • The effectiveness of serologic assays varies significantly across different STD pathogens, with specific strengths and limitations identified.
  • For conditions like syphilis, serology is a key indicator of successful intervention and treatment outcomes.

Conclusions:

  • Serologic testing remains an essential tool in the comprehensive management of STDs.
  • Understanding the performance characteristics of different serologic tests is vital for accurate diagnosis and effective public health strategies.
  • Continued research is needed to refine existing assays and develop new serologic markers for emerging STD challenges.